Company
Goldman Sachs Alternatives
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Owner | Funding | 2026-08-31 | Lead |
| Socure | Funding | 2026-08-27 | |
| Ramp | Series F | 2026-06-04 | |
| AlphaSense | Funding | 2026-06-04 | |
| Harness | Series E | 2025-12-11 | Lead |
| Judi Health | Funding | 2025-09-23 | |
| Attovia Therapeutics | Series C | 2025-04-16 | Lead |
| SkySpecs | Funding | 2025-03-20 | Lead |
| Newleos Therapeutics | Series A | 2025-02-13 | Lead |
| BrightNight | Equity Investment | 2024-10-07 | |
| Triveni Bio | Series B Funding | 2024-10-02 | Lead |
| AlphaSense | Funding | 2024-06-12 | |
| Attovia Therapeutics | series b | 2024-05-10 | Lead |
| Grow Therapy | Series C Funding | 2024-04-08 | |
| Alterome Therapeutics | Series B Funding | 2024-04-08 | Lead |
| Divcon Controls | Investment | 2024-02-21 |